EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.1.1.77 | 3-(acyloxy)acyl group of bacterial toxin |
detoxification of LPS |
Bos taurus |
3-hydroxyacyl group of bacterial toxin + a fatty acid |
- |
? |
3.1.1.77 | 3-(acyloxy)acyl group of bacterial toxin + H2O |
- |
Bos taurus |
3-hydroxyacyl group of bacterial toxin + a fatty acid |
- |
? |
3.1.1.77 | more |
a decrease in neutrophil AOAH activity results in the appearance of lipopolysaccharide in the blood. Low blood neutrophil deacylation activity could be considered as a risk factor for severe clinical coliform mastitis |
Bos taurus |
? |
- |
? |
3.1.1.77 | 3-(acyloxy)acyl group of bacterial toxin |
detoxification of LPS |
Homo sapiens |
3-hydroxyacyl group of bacterial toxin + a fatty acid |
- |
? |
3.1.1.77 | 3-(acyloxy)acyl group of bacterial toxin + H2O |
- |
Homo sapiens |
3-hydroxyacyl group of bacterial toxin + a fatty acid |
- |
? |
3.1.1.77 | 3-(acyloxy)acyl group of bacterial toxin + H2O |
smooth LPS deacylated more slowly than rough LPS |
Homo sapiens |
3-hydroxyacyl group of bacterial toxin + a fatty acid |
palmitoleate released more slowly than myristate and laurate, 2-hydroxylaurate released more slowly than laurate |
? |
3.1.1.77 | diacylglycerol + H2O |
in vitro |
Homo sapiens |
? |
- |
? |
3.1.1.77 | diacylphosphatidylethanolamine + H2O |
- |
Homo sapiens |
? |
- |
? |
3.1.1.77 | glycerophospholipid + H2O |
in vitro |
Homo sapiens |
? |
- |
? |
3.1.1.77 | lipopolysaccharide + H2O |
- |
Homo sapiens |
? |
- |
? |